Acerta 54


Prolonged-release tablet
scheduling status
S6
registration number
51/1.2/0288
What Acerta 54 contains
Methylphenindate HCl 54 mg.
other ingredients
Tablet content: fumaric acid, hypromellose, lactose monohydrate, magnesium stearate, methacrylic acid–methyl methacrylate copolymer, colloidal anhydrous silica, triethyl citrate and talc Tablet coating: iron oxide red (E172), macrogol (3350), part hydrolysed polyvinyl alcohol, talc and titanium dioxide (E171) Printing ink: iron oxide black (E172), isopropyl alcohol and shellac glaze.
Therapeutic classification
N06B A04 - centrally acting sympathomimetics.
© 2026 SAHPRA. ALL RIGHTS RESERVED